// App-Quantinova.ai

545 : Incidence of Infusion Reactions to Intravenous Golimumab: Results from a Prospective, Real-World Community Registry

Researchers

Presenter

  • Rafat Faraawi

Principal Investigators

  • Andrew Chow

  • Majed M M Khraishi

  • Derek Haaland

  • Milton F. Baker

  • Cathy Tkaczyk

  • Allen J Lehman

  • Francois Nantel

  • Brendan Osborne

Medical Centers

  • McMaster University, Hamilton, ON, Canada

  • Credit Valley Rheumatology, Mississauga, ON, Canada

  • Faculty of Medicine, Memorial University of Newfoundland, St. Johns, NF, Canada

  • Rheumatology, Clinical Immunology & Allergy, McMaster University, Barrie, ON, Canada

  • VIHA, Victoria, BC, Canada

  • Medical Affairs, Janssen Inc., Toronto, ON, Canada

  • Janssen Inc., Toronto, ON, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • golimumab

Outcome

  • N/A

Study Design

  • Observational

  • Non Interventional

  • Multicenteric

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved